Institut Cancerologie de l'Ouest: Prostatic Neoplasms trials
The registry lists 10 Prostatic Neoplasms studies with Institut Cancerologie de l'Ouest as lead sponsor. 1 are open to participants now and 2 have results posted.
Phase 1 2Phase 2 2No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder CancerNot yet recruitingNCT07468838
- Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate CancerCompletedNCT02274779Phase 2Results posted
- Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal CancersCompletedNCT01325961Not applicableResults posted
- Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate TumorsCompletedNCT04704804
- Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by MetforminActive, not recruitingNCT04536805Phase 1/2
- Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate CancersStatus unknownNCT03961737Not applicable
- Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer PatientsActive, not recruitingNCT03630666Not applicable
- Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate CancerCompletedNCT03443609Not applicable
- Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate CancerCompletedNCT02876237Not applicable
- ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate AdenocarcinomaCompletedNCT01219790Phase 1